Guideline / position statementindependent cross-checkfull text checked★ key study I-INTC-03 in-depth review
US diabetes guideline on food and lifestyle
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026.
Overview
American Diabetes Association Professional Practice Committee. Diabetes Care 2026 · PMID 41358898 · DOI 10.2337/dc26-S005
There is no single diet for diabetes; meals should be individualised with a dietitian, and medicines may need adjustment when the diet changes.
Does the study support the specific claim? Partly · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Give lifestyle and nutrition recommendations for diabetes
- How was the study done?
Evidence-graded guideline
- How many people, animals or samples were studied?
People with prediabetes or diabetes
- What was actually found?
Individualised plans; emphasise vegetables, legumes, whole grains; limit sugary drinks and ultra-processed foods
- How large was the observed effect?
Grade B recommendations
- What do the results mean in everyday life?
Changing your diet with diabetes is good but should be planned with your care team, especially if you take insulin.
- What are the study's limitations?
US guideline; not specific to Egypt
- What does it say about Elawady's specific claim?
Supports the caution on the third-party pages but not the exclusion of legumes, vegetables and dairy
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Whether the Tayebat system helps any disease
Scientific in-depth review
1. Full reference
- Authors
- American Diabetes Association Professional Practice Committee
- Journal
- Diabetes Care
- Year
- 2026
- Identifier
- PMID 41358898 DOI 10.2337/dc26-S005
- Verification
- verified – PubMed efetch 2026-10-25; full text read at https://pmc.ncbi.nlm.nih.gov/articles/PMC12690188/
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
Duality of interest information for each contributor at https://doi.org/10.2337/dc26-SDIS (not reviewed)
2. Research question
What lifestyle and nutrition recommendations apply to people with prediabetes and diabetes?
3. Study design and population
- Study design
- Guideline / position statement – Clinical practice guideline section (ADA Standards of Care 2026, section 5: lifestyle and nutrition)
- Population
People with prediabetes or diabetes
- Country
USA (international use)
- Period
2026 edition
- Sample size
not applicable
- Inclusion and exclusion criteria
Evidence graded by the ADA system (A/B/C/E)
4. Methods and endpoints
- Exposure / intervention
Nutrition therapy, eating patterns, physical activity, behaviour
- Comparator
not applicable
- Endpoints
Glycaemia, weight, cardiometabolic outcomes
- Statistical methods
Graded recommendations
5. Actual results
- Results
Full text (PMC12690188, read 2026-10-25): 'there is no one-size-fits-all eating pattern for individuals with diabetes, and meal planning should be individualized'; all people with diabetes should be referred for individualised medical nutrition therapy by a registered dietitian nutritionist. Rec. 5.14 (grade B): eating patterns should emphasise nonstarchy vegetables, whole fruits, legumes, lean proteins, whole grains, nuts and seeds, and low-fat dairy or nondairy alternatives, and minimise red meat, sugar-sweetened beverages, sweets, refined grains, processed and ultraprocessed foods. Very-low-carbohydrate plans need consistent medical oversight; insulin and other diabetes medications may need adjustment to prevent hypoglycaemia; such plans are not currently recommended in pregnancy or lactation, children, kidney disease or disordered eating.
- Absolute risks
not applicable
- Authors' conclusion
Individualised nutrition therapy under professional supervision is part of diabetes care; several dietary patterns can be appropriate.
6. Strengths
- Annually updated, evidence-graded guideline
- Full text read for the cited passages
7. Weaknesses
- US-focused
- Only the nutrition passages quoted here were read in detail
8. Risk of bias
- Orienting tool
- AMSTAR 2
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- low
- Rationale
Guideline with an explicit grading system; not formally appraised here (formal: false).
9. Assessment of the statistical interpretation
Grade B recommendations; no single effect size.
10. Relevance to the specific claim
Agrees with the third-party pages that dietary change in diabetes should be supervised and that medicines may need adjustment; partly conflicts with the Tayebat lists, which exclude legumes, most vegetables and liquid dairy that the guideline recommends, while both advise limiting sugar-sweetened beverages and ultra-processed foods.
11. Independent contrary findings
None.
12. Transferability to Germany and Europe
European guidance (EASD) is broadly similar on individualisation (not audited here).
13. Overall methodological judgement
Authoritative reference for medically supervised nutrition therapy in diabetes.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | low |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
No trial of the Tayebat system exists.